Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03 Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Carcinoma, Squamous Cell
  • Head and Neck Neoplasms
  • Protein-Lysine 6-Oxidase

abstract

  • AQUA LOX expression was strongly associated with increased metastasis, progression, and death in RTOG 90-03 patients. This study validates that LOX is a marker for metastasis and survival in HNC.

publication date

  • September 10, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2744270

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.20.6003

PubMed ID

  • 19667273

Additional Document Info

start page

  • 4281

end page

  • 6

volume

  • 27

number

  • 26